Sponsor:
GlaxoSmithKline
Code:
NCT07915791
Conditions
Pulmonary Disease, Chronic Obstructive
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
GSK3862995B
GSK5784283
Placebo
Brief summary:
Conditions
Pulmonary Disease, Chronic Obstructive
Study ID
NCT07915791
Start date
Oct 29, 2026
Status verified date
Nov, 2026
Completion date
Feb 6, 2030
Anticipated
Primary completion date
Mar 7, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Enrollment
279 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: GSK3862995B co-administered with GSK5784283
placebo comparator: Placebo
Interventions
GSK3862995B
GSK5784283
Placebo
Primary outcome measure
Central contacts
Locations
GSK Investigational Site
Recruiting
Newport Beach, California, United States, 92663
Contacts
Principal Investigator:
Ryan Klein
GSK Investigational Site
Recruiting
Miami, Florida, United States, 33176-7016
Contacts
Principal Investigator:
Andrew Pastewski
GSK Investigational Site
Recruiting
Derby, Kansas, United States, 67037
Contacts
Principal Investigator:
Scott Meyers
GSK Investigational Site
Recruiting
Columbia, Maryland, United States, 21045
Contacts
Principal Investigator:
David Nyanjom
GSK Investigational Site
Recruiting
Oklahoma City, Oklahoma, United States, 73111
Contacts
Principal Investigator:
Charles Lunn
GSK Investigational Site
Recruiting
Philadelphia, Pennsylvania, United States, 19107
Contacts
Principal Investigator:
David Wheeler
GSK Investigational Site
Recruiting
Rock Hill, South Carolina, United States, 29732
Contacts
Principal Investigator:
Michael Denenberg
GSK Investigational Site
Recruiting
Tomball, Texas, United States, 77375
Contacts
Principal Investigator:
Amanbir Sohal
Sponsor
GlaxoSmithKline
Last update posted
Nov 17, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-18. This information was provided to ClinicalTrials.gov by GlaxoSmithKline on 2026-11-17. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.